Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE. Read more about Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Hyperuricemia reduces neutrophil function. Read more about Hyperuricemia reduces neutrophil function.
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Read more about BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Read more about International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
Neutrophils in acute inflammation: current concepts and translational implications. Read more about Neutrophils in acute inflammation: current concepts and translational implications.
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. Read more about Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Treating CAR-T relapses: check not checkmate. Read more about Treating CAR-T relapses: check not checkmate.
Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, thrombocytosis, and mutated JAK2/SF3B1 without anemia. Read more about Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, thrombocytosis, and mutated JAK2/SF3B1 without anemia.
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Read more about Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
